Verition Fund Management
INBX

Verition Fund Management’s Inhibrx, Inc. Common Stock INBX Stock Holding History

Verition Fund Management’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-95,076
Closed -$1.08M – 3367
2022
Q2 		$1.08M Buy
+95,076
New +$1.4M 0.02% 978

Other funds holding INBX

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Verition Fund Management's INBX Position: Q3 2022 in Review

Verition Fund Management sold out of Inhibrx, Inc. Common Stock (INBX) in Q3 2022, closing a stake of 95,076 shares — an estimated $1.08M sold.

Verition Fund Management first reported a position in INBX in Q2 2022 and held it in 1 quarter. The position peaked at $1.08M in Q2 2022. 102 funds tracked by Wall St. Rank hold INBX as of Q3 2022.

  • Verition Fund Management reported no remaining Inhibrx, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Verition Fund Management sold 95,076 Inhibrx, Inc. Common Stock shares in Q3 2022, an estimated $1.08M.
  • Verition Fund Management first reported a position in Inhibrx, Inc. Common Stock in Q2 2022 and held it in 1 quarter.
  • Verition Fund Management's Inhibrx, Inc. Common Stock position peaked at $1.08M in Q2 2022.
  • 102 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q3 2022.

Based on Verition Fund Management's 13F filing for Q3 2022, filed 14 Nov 2022.